Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intra-Cellular Therapies Inc. buy BiotechBee

Intra-Cellular Therapies Inc.
Start price
€58.60
24.06.23 / 70%
Target price
€90.00
30.06.26
Performance (%)
18.43%
End price
€69.40
19.02.24
Summary
This prediction ended on 19.02.24 with a price of €69.40. The prediction had a final performance of 18.43%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intra-Cellular Therapies Inc. - - -
iShares Core DAX® -2,53 % -5,19 % 4,91 %
iShares Nasdaq 100 -0,03 % 1,56 % 21,79 %
iShares Nikkei 225® -4,20 % -7,55 % 31,13 %
iShares S&P 500 -0,80 % 0,16 % 15,78 %

According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Intra-Cellular Therapies Inc. diskutieren
Prediction Buy
Perf. (%) 18.43%
Target price 90.000
Change
Ends at 30.06.26

Buy mit Kursziel 90,0

BiotechBee 
0
Report Share
24.06.23
In the thread Trading Intra-Cellular Therapies Inc.
Prediction Buy
Perf. (%) 18.43%
Target price 90.000
Change
Ends at 30.06.26

Buy beendet

BiotechBee 
0
Report Share
19.02.24

Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.40
19.02.24
€85.00
30.09.25
15.27%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 70%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€44.49
23.09.22
€80.00
31.07.25
28.12%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
23.09.22 60%